Skip to content

Reduction of Postoperative Pain After Milligan-Morgan Haemorrhoidectomy With Application of Vitamin E Ointment

Reduction of Postoperative Pain and Improvement of Patients´Comfort After Milligan-Morgan Haemorrhoidectomy With Application of Vitamin E Ointment

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02554123
Enrollment
60
Registered
2015-09-18
Start date
2015-01-31
Completion date
2015-09-30
Last updated
2015-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Brief summary

A prospective ranfomized clinical study of patients undergoing Milligan Morgan´s haemorrhoidectomy at Hospital Universitario Rey Juan Carlos (Móstoles-Spain) will be performed. The patients will be randomized into 2 groups: * Experimental group (EG): Patients undergoing Milligan Morgan´s procedure and application of Vitamin E ointment on the surgical bed. * Control group (CG): Patients undergoing Milligan Morgan´s procedure and application of Vaseline on the surgical bed. Postoperative pain determined by VAS at the 1st, 3rd and 7th postoperative days, and need for morphine rescue will be investigated.

Detailed description

A prospective ranfomized clinical study of patients undergoing Milligan Morgan´s haemorrhoidectomy at Hospital Universitario Rey Juan Carlos (Móstoles-Spain) will be performed. The patients will be randomized into 2 groups: * Experimental group (EG): Patients undergoing Milligan Morgan´s procedure and application of Vitamin E ointment on the surgical bed. * Control group (CG): Patients undergoing Milligan Morgan´s procedure and application of Vaseline on the surgical bed. Postoperative pain determined by VAS at the 1st, 3rd and 7th postoperative days, and need for morphine rescue will be investigated by a blined epidemiology nurse.

Interventions

Vitamin E ointment application. Every 12 hours during 7 days.

DRUGVaseline ointment application

Vaseline ointment application. Every 12 hours during 7 days.

Sponsors

Hospital General Universitario Elche
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients undergoing Milligan Morgan´s haemorrhoidectomy at Hospital Universitario Rey Juan Carlos (Móstoles-Spain). * Haemorrhoids grade III and IV * The patients sign an Informed Consent Form agreeing their participation in the study.

Exclusion criteria

* Patients undergoing other surgical techniques for haemorrhoidectomy, different tan Milligan Morgan * Haemorrhoids grade I and II * Patients with medical or surgical pathologies that do not allow the participation in the study * Disability to understand and accept the entry in the study

Design outcomes

Primary

MeasureTime frameDescription
Postoperative painFrom the first to the 7th postoperative daysPostoperative pain will be quantified with a VAS scale at the 1st, 3rd and 7th postoperative days

Secondary

MeasureTime frameDescription
Need for morphine rescue24 hours after surgeryNeed for morphine rescue will be quantified in the first 24 hours after surgery during the hospital stay

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026